RP Bio lnc (XKRX:314140) Debt-to-Equity : 0.30 (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is RP Bio lnc Debt-to-Equity?

RP Bio lnc's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₩26,007 Mil. RP Bio lnc's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₩4,774 Mil. RP Bio lnc's Total Stockholders Equity for the quarter that ended in Dec. 2023 was ₩102,747 Mil. RP Bio lnc's debt to equity for the quarter that ended in Dec. 2023 was 0.30.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for RP Bio lnc's Debt-to-Equity or its related term are showing as below:

XKRX:314140' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.3 Med: 0.4 Max: 0.62
Current: 0.3

During the past 4 years, the highest Debt-to-Equity Ratio of RP Bio lnc was 0.62. The lowest was 0.30. And the median was 0.40.

XKRX:314140's Debt-to-Equity is ranked worse than
50.65% of 851 companies
in the Drug Manufacturers industry
Industry Median: 0.29 vs XKRX:314140: 0.30

RP Bio lnc Debt-to-Equity Historical Data

The historical data trend for RP Bio lnc's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RP Bio lnc Debt-to-Equity Chart

RP Bio lnc Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Debt-to-Equity

0.67

0.66

0.62

0.42

RP Bio lnc Quarterly Data
	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial					0.42	0.38	0.33	0.33	0.30

Competitive Comparison of RP Bio lnc's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, RP Bio lnc's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

RP Bio lnc's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, RP Bio lnc's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where RP Bio lnc's Debt-to-Equity falls into.

RP Bio lnc Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

RP Bio lnc's Debt to Equity Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(35549.916	+	2634.805)	/	91136.602
	=	0.42

RP Bio lnc's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(26006.961	+	4774.218)	/	102746.536
	=	0.30

RP Bio lnc (XKRX:314140) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

RP Bio lnc Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of RP Bio lnc's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

RP Bio lnc (XKRX:314140) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » RP Bio lnc (XKRX:314140) » Definitions » Debt-to-Equity

Traded in Other Exchanges

N/A

Address

634, Samseong-ro, Gangnam-gu, Seoul, KOR, 06084

Website

http://www.rpskorea.com

RP Bio lnc is engaged in the pharmaceutical manufacturing business. It produces softgels, finished drugs, and other products.

RP Bio lnc (XKRX:314140) Headlines

No Headlines